Henri Ey suggested that all hallucinations occur against the background of depersonalization, which is an alteration in experience that people find hard to describe, where the subject feels a strangeness pervading the world and her/his own body, emotions and thoughts. Embracing Ey’s proposal, this paper draws a comparison between depersonalization in hallucinations and depersonalization in some delusional states (especially the Capgras and the Cotard syndromes), which by the most recent models used in cognitive neuroscience is considered to be a disruption in so-called ‘affective familiarity’. Sensory information regarding the world is divided into the ‘overt pathway’ of perceptual inputs and the ‘covert pathway’ of ‘atmospheric cues’. In hallucinating subjects, we suggest that a breakdown of the grasping of atmospheric qualities in the environment triggers a compensatory process consisting of the production of hypotheses that make sense of the world perceived. Finally, we report on a case that illustrates our proposal.

1.
Blankenburg W: Der Verlust der natürlichen Selbstverständlichkeit. Ein Beitrag zur Psychopathologie symptomarmer Schizophrenien. Stuttgart, Ferdinand Enke, 1971.
2.
Sass L: Contradictions of emotion in schizophrenia. Cogn Emot 2007;21:351–390.
3.
Dugas L: Un cas de dépersonnalisation. Rev Philos Paris Etrang 1898;XLV:500–507.
4.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-IV, ed 4. Washington, American Psychiatric Association, 1997.
5.
Sierra M, Baker D, Medford N, David AS: Unpacking the depersonalization syndrome: an exploratory factor analysis on the Cambridge Depersonalization Scale. Psychol Med 2005;35:1523–1532.
6.
Saladini O, Luauté J: Dépersonnalisation. Encycl Méd Chir. Editions Scientifiques et Médicales. Paris, Elsevier, 2003, Psychiatrie, 37-125-A-10.
7.
Parnas J, Handest P: Phenomenology of anomalous self-experience in early schizophrenia. Compr Psychiatry 2003;44:121–134.
8.
Sedman G: Theories of depersonalization: a re-appraisal. Br J Psychiatry 1970;117:1–14.
9.
Sedman G: An investigation of certain factors concerned in the aetiology of depersonalization. Acta Psychiatr Scand 1972;48:191–219.
10.
Ackner B: Depersonalization. I. Aetiology and phenomenology. J Ment Sci 1954;100:838–853.
11.
Ey H: Traité des hallucinations. Paris, Masson, 1973.
12.
Maher BA: Anomalous experience in everyday life: its significance for psychopathology. Monist 1999;82:547–570.
13.
Maher BA, Ross JA: Delusions; in Adams HE, Sutker PB (eds): Comprehensive Handbook of Psychopathology. New York, Plenum, 1984.
14.
Gerrans P: A one-stage explanation of the Cotard delusion. PPP 2002;9:47–53.
15.
Davies M, Coltheart M, Langdon R, Breen N: Monothematic delusions: towards a two-factor account. PPP 2001;8:133–158.
16.
Capgras J, Reboul-Lachaux J: Illusions des sosies dans un délire systématisé chronique. Bull Soc Clin Med Ment 1923;11:6–16.
17.
Enoch MD, Trethowan WH: Uncommon Psychiatric Symptoms. Oxford, Butterworth-Heinemann, 1991.
18.
Berrios GA, Luque R: Cotard’s syndrome: analysis of 100 cases. Acta Psychiatr Scand 1995;91:185–189.
19.
Ey H: Etude 17: l’hypochondrie; in Etudes psychiatriques. Perpignan, Crehey, 2006, vol 2.
20.
Camus V, Schmitt L, Foulon C, DeMendonça Lima C, Wertheimer J: Pregnancy delusions in elderly depressed women: a clinical feature of Cotard’s syndrome? Int J Geriatr Psychiatry 1995;10:1071–1073.
21.
Ellis HD, Young AW: Accounting for delusional misidentifications. Br J Psychiatry 1990;157:239–248.
22.
Bauer RM: Autonomic recognition of names and faces in prosopagnosia: a neuropsychological application of the Guilty Knowledge Test. Neuropsychologia 1984;22:457–469.
23.
Breen N, Caine D, Coltheart M: Models of face recognition and delusional misidentification: a critical review. Cogn Neuropsychol 2000;17:55–71.
24.
Wright S, Young AW, Hellawell DJ: Sequential Cotard and Capgras delusions. Br J Clin Psychol 1993;32:345–349.
25.
Young AW, Leafhead KM, Szulecka TK: The Capgras and Cotard delusions. Psychopathology 1994;27:226–231.
26.
Ramachandran VS, Blakeslee S: Phantoms in the Brain. Human Nature and the Architecture of the Mind. London, Fourth Estate, 1998.
27.
Gerrans P: Refining the explanation of Cotard’s delusion. Mind Lang 2000;15:111–122.
28.
Berner P: Delusional atmosphere. Br J Psychiatry Suppl 1991;14:88–93.
29.
Mellor C: Delusional perception. Br J Psychiatry Suppl 1991;14:104–107.
30.
Berrios GE, Fuentenebro F: The predelusional state: a conceptual history. Compr Psychiatry 1995;36:251–259.
31.
Jaspers K: General Psychopathology. Manchester, Manchester University Press, 1963.
32.
Conrad K: Die beginnende Schizophrenie. Stuttgart, Thieme, 1958.
33.
Schneider K: General Psychopathology. New York, Grune & Stratton, 1959.
34.
Watts PM: A Qualitative Study of Emotional Experiences during the Pre-Psychotic Period; thesis, University of Auckland, 2006.
35.
Tellenbach H: Geschmack und Atmosphäre. Salzburg, Otto Müller, 1968.
36.
Heidegger M: Sein und Zeit. Halle, Max Niemeyer, 1927.
37.
Belzeaux P: La conception du négatif dans l’organo-dynamique d’Henry Ey: forme, figuralité et sens. International Congress of WPA Jubilee, 2000.
38.
Bovet P, Parnas J: Schizophrenic delusions: a phenomenological approach. Schizophr Bull 1993;19:579–597.
39.
Bayne T, Pacherie E: Experience, belief and the interpretive fold. PPP 2004;11:81–86.
40.
Sartre J-P: L’imaginaire. Psychologie phénoménologique de l’imagination. Paris, Gallimard, 1948.
41.
Merleau-Ponty M: La phénoménologie de la perception. Paris, Gallimard, 1945.
42.
Minkowski E: Le temps vécu. Etudes phénoménologiques et psychologiques. Paris, Quadrige/PUF, 1995.
43.
Ratcliffe M: Interpreting delusions. Phenomenol Cogn Sci 2004;3:25–48.
44.
Young G: Restating the role of phenomenal experience in the formation and maintenance of the Capgras delusion. Phenomenol Cogn Sci 2008;7:177–189.
45.
Scherer KR: Expression of emotion in voice and music. J Voice 1995;9:235–248.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.